# Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders

> **NCT00010335** · PHASE1 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 6 (actual)

## Conditions studied

- Systemic Sclerosis
- Systemic Lupus Erythematosus
- Dermatomyositis
- Juvenile Rheumatoid Arthritis
- Autoimmune Diseases

## Interventions

- **PROCEDURE:** Stem Cell Transplantation
- **DEVICE:** CD34 selection

## Key facts

- **NCT ID:** NCT00010335
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-11
- **Primary completion:** 2010-07
- **Final completion:** 2011-05
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2015-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00010335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00010335, "Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00010335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*